Our research center has many ongoing IRB APPROVED clinical trials targeted to various ailments and conditions. Your eligibility for a study is based on the study requirements. If you choose to participate, there is no cost to you during the study. Furthermore, all of the following services are provided at no cost to you.
For more information, please contact: DR MARIA AZIZ ,972-353-8616 Ext 105 or email email@example.com
RESEARCH STUDY SUMMARY:
A Phase 3 clinical study of ORAL DRUG X for patients with Type 2 Diabetes Mellitus with established vascular disease in the coronary ,cerebral or peripheral arteries.
This study will evaluate the efficacy and safety of ORAL DRUG X in participants with type 2 diabetes mellitus with established vascular disease in the coronary, cerebral or peripheral arteries.